TOKYO (Reuters) - Japanese biopharmaceutical firm Anges inc said on Thursday it would join hands with Osaka University to develop a coronavirus vaccine.
Shares of Anges were up more than 12% after the announcement.
There are now over 93,000 cases globally according to a Reuters tally, with 13% or almost 12,700 cases in countries outside China, including in Japan.
Reporting by Chris Gallagher; Editing by Shri Navaratnam
Our Standards: The Thomson Reuters Trust Principles.